Coagulation and inflammatory markers in Alzheimer's and vascular dementia

被引:68
作者
Gupta, A [1 ]
Watkins, A
Thomas, P
Majer, R
Habubi, N
Morris, G
Pansari, K
机构
[1] W Wales Hosp, Dept Med, Carmarthen SA31 2AF, Dyfed, Wales
[2] Univ Swansea, Dept Stat, Swansea, W Glam, Wales
[3] Prince Philip Hosp, Dept Med, Llanelli, Wales
[4] Prince Philip Hosp, Dept Haematol, Llanelli, Wales
[5] Prince Philip Hosp, Dept Pathol, Llanelli, Wales
[6] St Davids Hosp, Carmarthen, Dyfed, Wales
关键词
dementia; coagulation; inflammation;
D O I
10.1111/j.1368-5031.2004.00143.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Alzheimer's disease is classified as a degenerative dementia while vascular dementia is known to be associated with atherothrombosis and classical vascular risk factors. However, over the last decade, there is increasing evidence of the role of haemostatic factors and inflammatory mechanisms in the pathogenesis of Alzheimer's disease. Serum markers of hyper-coagulability and markers of inflammation could lead to thrombosis, accelerated atherogenesis and resulting dementia of both Alzheimer's and vascular dementia. In this case control study, we studied these serum markers of coagulation and inflammation in patients suffering from dementia.(C) 2004 Blackwell Publishing Ltd.
引用
收藏
页码:52 / 57
页数:6
相关论文
共 61 条
[1]  
Bermudez Edmund A, 2002, Prev Cardiol, V5, P42, DOI 10.1111/j.1520-037X.2002.1032.x
[2]   Projected life-expectancy gains with statin therapy for individuals with elevated C-reactive protein levels [J].
Blake, GJ ;
Ridker, PM ;
Kuntz, KM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (01) :49-55
[3]   ASSESSMENT OF HYPERCOAGULABLE STATES BY MEASUREMENT OF ACTIVATION FRAGMENTS AND PEPTIDES [J].
BOISCLAIR, MD ;
IRELAND, H ;
LANE, DA .
BLOOD REVIEWS, 1990, 4 (01) :25-40
[4]  
Bots ML, 1998, HAEMOSTASIS, V28, P216
[5]  
Breteler MMB, 1998, HAEMOSTASIS, V28, P167
[6]   Plasma lipoprotein(a) distribution in the Framingham Offspring Study as determined with a commercially available immunoturbidimetric assay [J].
Contois, JH ;
LammiKeefe, CJ ;
Vogel, S ;
McNamara, JR ;
Wilson, PWF ;
Massov, T ;
Schaefer, EJ .
CLINICA CHIMICA ACTA, 1996, 253 (1-2) :21-35
[7]   Cognitive function and blood rheology: results from the Caerphilly cohort of older men [J].
Elwood, PC ;
Pickering, J ;
Gallacher, JEJ .
AGE AND AGEING, 2001, 30 (02) :135-139
[8]   FIBRINOGEN AS A CARDIOVASCULAR RISK FACTOR - A METAANALYSIS AND REVIEW OF THE LITERATURE [J].
ERNST, E ;
RESCH, KL .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (12) :956-963
[9]   Prospective study of hemostatic factors and incidence of coronary heart disease - The Atherosclerosis Risk in Communities (ARIC) Study [J].
Folsom, AR ;
Wu, KK ;
Rosamond, WD ;
Sharrett, AR ;
Chambless, LE .
CIRCULATION, 1997, 96 (04) :1102-1108
[10]   C-Reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study [J].
Folsom, AR ;
Aleksic, N ;
Catellier, D ;
Juneja, HS ;
Wu, KK .
AMERICAN HEART JOURNAL, 2002, 144 (02) :233-238